lexicon pharmaceuticals inc
Transactions by LEXICON PHARMACEUTICALS INC (LXRX) in the last 6 months
Lexicon Pharmaceuticals, Inc. (NasdaqGS:LXRX) announced a private placement of common shares for gross proceeds of $4,662,780 on December 4, 2014.The company will issue securities pursuant to exemption provided under Regulation D. The transaction will include participation from 16 investors.
Lexicon Pharmaceuticals, Inc. (NasdaqGS:LXRX) announced that it has entered into a purchase agreement for a private placement of 149,253,731 common shares at a price of $1.005 per share for gross proceeds of $150,000,000 on November 20, 2014. The transaction will see participation from existing investor The Invus Group, LLC. The company will issue the securities pursuant to exemption provided under Regulation D. The company will receive net proceeds of $149,900,000 in ...
|Abbott Laboratories||$45.77 USD||+1.51|
|Boston Scientific Corp||$13.26 USD||+0.24|
|CR Bard Inc||$171.58 USD||+2.71|
|Johnson & Johnson||$106.81 USD||+2.74|
|Medtronic Inc||$74.63 USD||+1.96|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|